Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-084006

EVP, Chief Development Officer acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Forbes William P EVP, Chief Development Officer 2025-06-06 Option exercise +12,500 135,066 D
Derivatives
Forbes William P EVP, Chief Development Officer 2025-06-06 Option exercise · Restricted Stock Units −12,500 25,000 D
Loading xslF345X05/ownership.xml…